Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04151758Phase 4Unknown
Phase 4, open-label, single-arm trial, sponsored by University of Milan. Primary endpoints: Changes in gut microbiota composition at 8 months and Changes in short-chain fatty acid production by gut microbiota at 8 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04151758.